glp 1 drugs and gallbladder Risks with GLP-1 Weight Loss Medications GLP-1: Genetic Variants Related to
Description
Diabetes 65 , 17141723 (2016)
For Life & Health insurers, the potential impact includes fewer deaths, healthier workforces, stronger portfolios, and evolving approaches to underwriting and risk assessment
The randomized controlled trials (RCTs) summarized in Table 2 consistently demonstrate that GLP-1RAs, such as exenatide, semaglutide, and dulaglutide, significantly reduce albuminuria in patients with T2DM and CKD
It is necessary to educate patients on the prevention of hypoglycemia, especially because the function of -cells, which are responsible for counter-regulatory control, is lost
2022 Dec;118(6):11501158
Trulicity [package insert]
